Skip to main content

Table 3 Univariate analysis relationship between factors and survival

From: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Variable Hazard Ratio (95%) CI p value
Sex 1.163 (0.734–1.843) 0.519
Age 1.091 (0.699–1.704) 0.702
Tumour Differentiation 1.398 (0.879–2.224) 0.157
Tumor Stage 2.805 (1.749–4.499) < 0.001
Tumor location 1.102 (0.652–1.864) 0.716
Tumor Size 0.938 (0.587–1.499) 0.788
Metastasis status 9.482 (2.156–41.707) 0.003
Lymph Node Involvement 2.029 (1.292–3.188) 0.002
Vascular invastion 1.04 (0.659–1.64) 0.868
Transgelin2 p-S145 2.27 (1.42–3.627) 0.001